AWS Launches Life Sciences Toolkit with Generative AI to Empower Global Expansion of Chinese Medical Device Companies

In 2023, 61 innovative medical devices were approved in China, marking a record high; meanwhile, the export value of Chinese medical instruments and equipment reached US$18.418 billion, with a significant acceleration in the overseas expansion of high-value medical consumables.

The surge in innovative medical device products and their robust expansion into overseas markets signify that many Chinese medical innovations now possess the capability to compete on a global stage against the strongest rivals. However, significant differences across countries in cultural contexts, regulatory processes, data security compliance, and marketing systems pose substantial challenges for enterprises seeking global expansion.

To better support Chinese medical device companies in successfully expanding overseas, AWS recently hosted the “Medical Device Global Expansion Executive Salon” as part of its “Setting Sail” series in Shanghai. Joining hands with leading enterprises in niche segments of China’s medical device industry, the event facilitated in-depth discussions on global expansion strategies.

Yue Chen, Director of Healthcare and Life Sciences at AWS

In the opening remarks, the Director of Healthcare and Life Sciences at Amazon Web ServicesChen YueIt is noted that, on the one hand, emerging technologies such as artificial intelligence, the Internet of Things (IoT), and big data have injected new momentum into innovation within the medical device industry; on the other hand, challenges related to regulatory compliance, data security, and cost control are placing greater pressure on enterprises. Many competitive domestic companies are also setting their sights on overseas markets. By leveraging the efficient, flexible, and cost-effective IT infrastructure provided by cloud computing, they are rapidly expanding their presence in the vast global market, giving rise to a number of “hidden champions” in niche segments.

At the conference, Huang Qingchun, Senior Director of Healthcare and Life Sciences Solutions at Amazon Web Services (AWS), addressed the pain points and challenges faced by medical device manufacturers expanding into overseas markets, and introducedAWS Healthcare and Life Sciences Global Expansion Toolkit, providing comprehensive solutions for medical device companies expanding overseas. Fu Wenteng, Director of Business Development for East and North China at Amazon Business, shared specific practices on how “Amazon Business” empowers Chinese medical device manufacturers to go global.

The event also invited experts, scholars, and industry executives from leading organizations and medical device companies, including Frost & Sullivan, Zhong Lun Law Firm, PureCert, Angelalign, and Yunshi Data. They shared corporate experiences in expanding medical device businesses overseas and discussed how to leverage Amazon Web Services’ technical solutions to tap into global markets.

Amazon Web Services is becoming the preferred partner for a growing number of Chinese companies expanding overseas.

One set of data speaks for itself: this cloud computing leader operates a global network of data centers and offers more than 200 fully featured cloud services. According to the latest IDC data, Amazon Web Services (AWS) holds a dominant lead in the market for Chinese enterprises going global and using overseas public cloud IaaS resources, with a market share approaching 80%.

Amazon Web Services (AWS) has consistently been a driving force behind digital transformation and innovation in the healthcare and life sciences industry. In 2013, AWS established a global Healthcare and Life Sciences team, and it now serves thousands of customers in this sector worldwide, including more than 400 Chinese enterprises, accumulating extensive successful practices and experience.

Leveraging its rich and stable cloud services, global infrastructure, extensive expertise in international expansion planning, and premium support, Amazon Web Services (AWS) is empowering Chinese healthcare and life sciences enterprises to expand globally with greater ease through digital technologies, thereby achieving sustained business growth.

Huang Qingchun, Senior Director of Healthcare and Life Sciences Solutions at Amazon Web Services

Medical devices are a key life sciences segment that Amazon Web Services prioritizes. Senior Director, Healthcare and Life Sciences Solutions, Amazon Web ServicesHuang QingchunIt is stated that while domestic competition in the life sciences industry is currently intense, overseas medical device niche markets hold immense potential. Although price pressures from China’s centralized procurement programs are intensifying, Chinese-made devices demonstrate significant global advantages in cost-effectiveness. Consequently, expanding into international markets to generate revenue has become an imperative path for the development of Chinese medical device enterprises. Furthermore, as China’s R&D capabilities in medical devices steadily strengthen—transitioning gradually from “low-price” to “high-quality”—and coupled with diverse overseas payment models, the life sciences industry’s global expansion has entered a fast-track lane.

However, the path to global expansion is fraught with challenges. Chinese medical device companies face five major risk management and global operational challenges: market access, clinical innovation, compliance and regulation, channel partnerships, and global management. For instance, policy regulations and laws vary significantly across different countries and regions, imposing high and ongoing compliance requirements on enterprises.

Digitalization has become a key lever for addressing the aforementioned challenges. In the digital era, digital technologies such as artificial intelligence, big data, and cloud computing not only reduce costs through end-to-end integration but also optimize and upgrade enterprises’ core capabilities and business models.

Thus, AWS, with its global infrastructure, extensive cloud service ecosystem, and rich experience in supporting international expansion, has become the preferred partner for many Chinese medical device companies going global.

To better support Chinese medical device companies in expanding overseas,AWS and Partners Launch Healthcare and Life Sciences Global Expansion Toolkit, providing life sciences enterprises with cloud computing-based digital technologies and methodologies that span the entire process of global expansion—from strategic design to implementation—helping medical device companies develop differentiated products, enhance their core global competitiveness, and deliver end-to-end support for their international growth.

According to Huang Qingchun, Amazon Web Services (AWS) safeguards enterprises by leveraging its global infrastructure and generative AI capabilities in areas such as market access registration, innovation capacity, global clinical operations, international regulatory compliance for pharmaceuticals and medical devices, overseas marketing network development, and global intelligent management.

AtOverseas Market AccessIn this regard, AWS provides enterprises with comprehensive business support throughout the entire process—from initial implementation and exploration, to product-market fit, and overseas business expansion—empowering them to build a global business ecosystem.

AboutClinical Innovation, AWS offers a variety of generative AI large language models that cover business scenarios such as product design, clinical validation, raw material manufacturing, and market launch, helping enterprises enhance their innovation capabilities and achieve comprehensive coverage of clinical operations.

ForInternational Compliance in Pharmaceutical and Medical Device Regulation, AWS has accumulated extensive experience over the years and has obtained more than 50 global healthcare and pharmaceutical compliance certifications, such as HIPAA/HITRUST in the United States and GDPR in Europe, while supporting the global GxP framework and Computerized System Validation (CSV) standards. Meanwhile, the AWS cloud computing platform leverages generative AI to promptly identify compliance risks for enterprises expanding overseas and provide response strategies and recommendations.

Then, across various countries and regionsMarketing Network DevelopmentAmazon Web Services (AWS) offers customers multiple channels, including AWS Marketplace and Amazon Business. AWS Marketplace is a curated digital catalog that helps customers find, subscribe to, deploy, and manage third-party software, data, and services. On May 6, AWS Marketplace (China Region) launched self-service management and online transaction capabilities for sellers, streamlining the software purchasing and deployment process for customers, further enhancing the platform’s user experience, and creating additional sales opportunities for partners.

Fu Wenteng, Director of Merchant Acquisition for East and North China, Amazon Business

Amazon Business is an online procurement service designed for enterprise and institutional customers. Director of Merchant Acquisition, East and North China Region, Amazon BusinessFu WentengAt the conference, it was announced that Amazon Business adopts a one-stop cross-border e-commerce DTB (Direct to Buyer) model. This approach helps Chinese sellers expand their individual end-consumer business through Amazon Global Selling while also directly reaching end-business buyers, thereby tapping into the blue ocean of B2B procurement with greater efficiency and lower costs.

Furthermore, Amazon Marketplace and Amazon Business will leverage Amazon Web Services’ proprietary resources in logistics and advertising, along with a global network of over 130,000 partners, to create broader opportunities for Chinese medical device enterprises to expand their overseas operations.

Finally, forGlobal Management, leveraging its extensive and in-depth cloud services, Amazon Web Services provides enterprises with an intelligent management system spanning the globe, as well as a global digital innovation and management cultural system refined over 30 years, helping enterprises achieve business and organizational innovation.

It is worth noting that,Amazon Web Services also unveiled a major suite of new technologies and services centered around generative AI., empowering enterprises to actively embrace generative AI and usher in the era of enterprise-grade generative AI. Among these offerings, the fully managed generative AI service Amazon Bedrock helps customers rapidly build and scale generative AI applications.

Amazon Bedrock features include model fine-tuning, retrieval-augmented generation (RAG), and pre-training of large image generation models. Enterprises can leverage Amazon Bedrock to access leading foundation models, such as Meta Llama 2 and Anthropic Claude, via simple API interfaces in a secure environment without managing any infrastructure. This enables them to build and scale generative AI applications while ensuring privacy and security, thereby significantly lowering the barrier for customers to transition from foundation models to developing generative AI applications.

“China’s First Listed Orthodontics Company” Angelalign has established in-depth cooperation with Amazon Web Services (AWS) in its overseas expansion. Since commercializing its international business in 2023, Angelalign has expanded into Europe, the United States, and the Asia-Pacific region, bringing to the fore challenges such as high levels of customization, localization, and data security compliance.

 Li Gen, Vice President of Information Technology at Angelalign

Vice President of Information Technology, AngelalignLi GenAt the conference, Dr. shared that, considering Amazon Web Services’ extensive and in-depth cloud services, data security and compliance capabilities, and globally covered infrastructure, Angelalign has chosen to partner with Amazon Web Services to implement its global strategy.

By partnering with Amazon Web Services (AWS), Angelalign completed the global deployment of its iOrtho digital orthodontic intelligent service platform in just four months, finishing infrastructure construction 50% ahead of schedule. This achievement resulted in a 20% reduction in total infrastructure costs and a significant enhancement in user experience. According to Angelalign’s annual report, the company handled 33,000 international cases in 2023, accounting for 13.5% of its total case volume.

Many selected ecosystem partners from the AWS Healthcare and Life Sciences Global Expansion Toolkit also attended the event, sharing their insights on the topic of “Global Expansion of Medical Devices.”

 Meng Zhu, Chairman of PureCert

PureSino is a SaaS-based medical device CRO. Chairman of PureSinoMeng ZhuIt stated that, through its in-depth collaboration with Amazon Web Services (AWS), Purui Chunzheng provides end-to-end global market compliance and access services for medical devices, in vitro diagnostics (IVD), and AI-driven medical software, deeply connecting various dimensions and practical scenarios of medical device expansion into overseas markets.

 He Dan, Co-founder of Yunshi Data

Yunshi Data, Senior Consulting Partner of Amazon Web Services, Co-founderHe Danalso shared how Yunshi Data, in its efforts to help enterprises expand globally, integrates GenAI technology into its solutions based on services such as Amazon Bedrock.ConnectNow Omnichannel Cloud Contact Center Platform, and serves the entire customer interaction lifecycle—from sales outreach to customer service. By mapping the customer journey, it leverages AI to optimize user experience and comprehensively enhance service and operational efficiency, helping enterprises expand globally and better implement localized services.

Li Qian, Director of Life Sciences Consulting at Frost & Sullivan

Dong Jianping, Equity Partner at Zhong Lun Law Firm

Additionally, Director of Life Sciences Consulting at Frost & SullivanLi Qian, Equity Partner at Zhong Lun Law FirmDong JianpingThey also shared insights on the challenges and opportunities for medical device companies expanding overseas, from the perspectives of industry research and legal regulation, as well as considerations regarding cross-border data compliance in the global expansion of medical devices.

Overall, digitalization and cloud services have become essential infrastructure for Chinese medical device companies expanding into global markets. AWS is being chosen by an increasing number of healthcare and life sciences enterprises, leveraging its globally distributed infrastructure, comprehensive and stable cloud services, systematic expertise in international expansion, and high-quality support. As a cloud computing leader in the life sciences industry, AWS aims to collaborate with industry stakeholders to jointly identify optimal solutions for enterprise digital transformation.